Filing Details
- Accession Number:
- 0001209191-14-074317
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-10 20:39:46
- Reporting Period:
- 2014-12-09
- Filing Date:
- 2014-12-10
- Accepted Time:
- 2014-12-10 20:39:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1429560 | Trevena Inc | TRVN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1228865 | Jr O Leon Moulder | 18131 Via Caprini Drive Miromar Lakes FL 33913-7609 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-12-09 | 30,200 | $3.96 | 30,200 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2014-12-10 | 19,800 | $4.06 | 50,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in several transactions at prices ranging from $3.94 - $3.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in several transactions at prices ranging from $3.95 - $4.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.